leisure time -WSS

leisure time

author：fashion 2025-09-27 09:45:24 - browse：2

Ron Wyden, left, and Mike Crapo, right. -- health policy coverage from STAT — Sens. Ron Wyden and Mike Crapo passed a new slate of pharmacy benefit manager reforms through the Finance Committee. Kevin Dietsch/Getty Images

WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy reforms that would rein in certain pharmacy middlemen practices and ensure Medicare patients aren’t paying more than insurers do for medications.

The package passed the committee 26-0 with no amendments added. Sen. Ron Johnson (R-Wis.) didn’t vote.

The package, crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) also includes policy on a broad range of health care priorities, including substance abuse and mental health care and extensions to provider pay. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： 'Make People Better': The CRISPR babies story you probably don't know

focus

WSS

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Some of the ways extreme heat will change life as we know it

Crinetics acromegaly drug succeeds in late

Listen: Your guide to Wegovy's blockbuster heart study

AstraZeneca chief proposes a novel edit to the drug pricing bill

CDC overhauls leadership of center that led response to Covid

explore

leisure time

focus

Jerome Adams on the need for new antivirals for Covid

Listen: Your guide to Wegovy's blockbuster heart study

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Listen: Your guide to Wegovy's blockbuster heart study

In Memoriam: Notable people who died in 2023

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

Drug repurposing or repositioning? The language matters

Large hospital system sues Multiplan for low

How one medical school became remarkably diverse

'Make People Better': The CRISPR babies story you probably don't know

hotspot

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Amazon on where the company's health care bets are headed next

Advances in CAR

Advances in CAR

'Make People Better': The CRISPR babies story you probably don't know

Genentech weighs delaying cancer therapy after drug pricing law

hotspot

focus

hotspot

hotspot